TLR9 provokes inflammation in response to fetal DNA: Mechanism for fetal loss in preterm birth and preeclampsia

Journal of Immunology

Volumn 188, Issue 11, 2012, Pages 5706-5712

  Scharfe Nugent, Andrea ^a   Corr, Sinéad C ^b   Carpenter, Susan B ^c   Keogh, Louise ^a   Doyle, Brendan ^a   Martin, Cara ^a   Fitzgerald, Katherine A ^c   Daly, Sean ^a   O'Leary, John J ^a   O'Neill, Luke A J ^b  

^a Tallaght and Coombe Women's and Infant's University Hospital   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CPG OLIGODEOXYNUCLEOTIDE; DNA; FETAL DNA; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FETUS; FETUS RESORPTION; FETUS WASTAGE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ADULT; ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; DNA; FEMALE; FETAL DEATH; HUMANS; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; PRE-ECLAMPSIA; PREGNANCY; PREMATURE BIRTH; TOLL-LIKE RECEPTOR 9;

EID: 84862059620     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103454     Document Type: Article

References (42)

1. Ehrenhaft, P. M., J. L. Wagner, and R. C. Herdman. 1989. Changing prognosis for very low birth weight infants. Obstet. Gynecol. 74: 528-535. (Pubitemid 19212929)
2. Goldenberg, R. L., J. D. Iams, B. M. Mercer, P. J. Meis, A. H. Moawad, R. L. Copper, A. Das, E. Thom, F. Johnson, D. McNellis, et al NICHD MFMU Network. 1998. The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. Am. J. Public Health 88: 233-238. (Pubitemid 28134082)
3. Goldenberg, R. L., J. F. Culhane, J. D. Iams, and R. Romero. 2008. Epidemiology and causes of preterm birth. Lancet 371: 75-84.
4. Tsang, J. C., and Y. M. Lo. 2007. Circulating nucleic acids in plasma/serum. Pathology 39: 197-207. (Pubitemid 46439650)
5. Morgan, M. A., R. L. Goldenberg, and J. Schulkin. 2008. Obstetrician-gynecologists'screening and management of preterm birth. Obstet. Gynecol. 112: 35-41.
6. Adams, M. M., L. D. Elam-Evans, H. G. Wilson, and D. A. Gilbertz. 2000. Rates of and factors associated with recurrence of preterm delivery. JAMA 283: 1591-1596. (Pubitemid 30161515)
7. Kim, Y. M., R. Romero, T. Chaiworapongsa, G. J. Kim, M. R. Kim, H. Kuivaniemi, G. Tromp, J. Espinoza, E. Bujold, V. M. Abrahams, and G. Mor. 2004. Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am. J. Obstet. Gynecol. 191: 1346-1355. (Pubitemid 39421595)
8. Hirsch, E., and H. Wang. 2005. The molecular pathophysiology of bacterially induced preterm labor: insights from the murine model. J. Soc. Gynecol. Investig. 12: 145-155. (Pubitemid 40387807)
9. Yoon, B. H., R. Romero, J. B. Moon, S. S. Shim, M. Kim, G. Kim, and J. K. Jun. 2001. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am. J. Obstet. Gynecol. 185: 1130-1136. (Pubitemid 33097376)
10. Kenyon, S. L., D. J. Taylor, and W. Tarnow-Mordi; ORACLE Collaborative Group. 2001. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. Lancet 357: 989-994. (Pubitemid 32285390)
11. Andrews, W. W., B. M. Sibai, E. A. Thom, D. Dudley, J. M. Ernest, D. McNellis, K. J. Leveno, R. Wapner, A. Moawad, M. J. O'Sullivan, et al; National Institute of Child Health & Human Development Maternal-Fetal Medicine Units Network. 2003. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet. Gynecol. 101: 847-855. (Pubitemid 36561243)
12. Iams, J. D., R. Romero, J. F. Culhane, and R. L. Goldenberg. 2008. Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet 371: 164-175.
13. Shennan, A., S. Crawshaw, A. Briley, J. Hawken, P. Seed, G. Jones, and L. Poston. 2006. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. BJOG 113: 65-74.
14. Steel, J. H., S. Malatos, N. Kennea, A. D. Edwards, L. Miles, P. Duggan, P. R. Reynolds, R. G. Feldman, and M. H. Sullivan. 2005. Bacteria and inflammatory cells in fetal membranes do not always cause preterm labor. Pediatr. Res. 57: 404-411. (Pubitemid 40293609)
15. Wataganara, T., and D. W. Bianchi. 2004. Fetal cell-free nucleic acids in the maternal circulation - new clinical applications. Ann. N. Y. Acad. Sci. 1022: 90-99. (Pubitemid 38951587)
16. Wataganara, T., A. Y. Chen, E. S. LeShane, L. M. Sullivan, L. Borgatta, D. W. Bianchi, and K. L. Johnson. 2004. Cell-free fetal DNA levels in maternal plasma after elective first-trimester termination of pregnancy. Fertil. Steril. 81: 638-644. (Pubitemid 38376122)
17. Lo, Y. M., M. S. Tein, T. K. Lau, C. J. Haines, T. N. Leung, P. M. Poon, J. S. Wainscoat, P. J. Johnson, A. M. Chang, and N. M. Hjelm. 1998. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am. J. Hum. Genet. 62: 768-775. (Pubitemid 28194317)
18. Leung, T. N., J. Zhang, T. K. Lau, N. M. Hjelm, and Y. M. Lo. 1998. Maternal plasma fetal DNA as a marker for preterm labour. Lancet 352: 1904-1905. (Pubitemid 28561255)
19. Bianchi, D.W. 2004. Circulating fetal DNA: its origin and diagnostic potential - a review. Placenta 25(Suppl A): S93-S101. (Pubitemid 38514964)
20. Cotter, A. M., C. M. Martin, J. J. O'leary, and S. F. Daly. 2004. Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia. Am. J. Obstet. Gynecol. 191: 515-520. (Pubitemid 39178706)
21. Yuen, R. K., M. S. Peñaherrera, P. von Dadelszen, D. E. McFadden, and W. P. Robinson. 2010. DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia. Eur. J. Hum. Genet. 18: 1006-1012.
22. Thaxton, J. E., R. Romero, and S. Sharma. 2009. TLR9 activation coupled to IL- 10 deficiency induces adverse pregnancy outcomes. J. Immunol. 183: 1144-1154.
23. Prater, M. R., V. J. Johnson, D. R. Germolec, M. I. Luster, and S. D. Holladay. 2006. Maternal treatment with a high dose of CpG ODN during gestation alters fetal craniofacial and distal limb development in C57BL/6 mice. Vaccine 24: 263-271. (Pubitemid 41790429)
24. Sasaki, Y., K. Otsuki, A. Hasegawa, M. Sawada, H. Chiba, M. Negishi, M. Nagatsuka, and T. Okai. 2004. Preventive effect of recombinant human lactoferrin on lipopolysaccharide-induced preterm delivery in mice. Acta Obstet. Gynecol. Scand. 83: 1035-1038. (Pubitemid 39457480)
25. Stoll, T., E. Huber, S. Bachmann, H. R. Baumeler, S. Mariacher, M. Rutz, W. Schneider, H. Spring, A. Aeschlimann, G. Stucki, and W. Steiner. 2004. Validity and sensitivity to change of the NASS questionnaire for patients with cervical spine disorders. Spine 29(24): 2851-2855.
26. Sharma, A., A. Satyam, and J. B. Sharma. 2007. Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am. J. Reprod. Immunol. 58: 21-30. (Pubitemid 46939024)
27. Rutz, M., J. Metzger, T. Gellert, P. Luppa, G. B. Lipford, H. Wagner, and S. Bauer. 2004. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur. J. Immunol. 34: 2541-2550. (Pubitemid 39302811)
28. Ballantyne, C. 2008. Mystery of preterm birth prompts search for better models. Nat. Med. 14: 793.
29. Essien, E. E., and G. C. Afamefuna. 1982. Chloroquine and its metabolites in human cord blood, neonatal blood, and urine after maternal medication. Clin. Chem. 28: 1148-1152. (Pubitemid 12116682)
30. Thomson, A. J., J. F. Telfer, A. Young, S. Campbell, C. J. Stewart, I. T. Cameron, I. A. Greer, and J. E. Norman. 1999. Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process. Hum. Reprod. 14: 229-236. (Pubitemid 29046344)
31. Romero, R., J. Espinoza, L. F. Gonçalves, J. P. Kusanovic, L. A. Friel, and J. K. Nien. 2006. Inflammation in preterm and term labour and delivery. Semin. Fetal Neonatal Med. 11: 317-326. (Pubitemid 44038705)
32. Yoon, B. H., R. Romero, C. J. Kim, J. K. Jun, R. Gomez, J. H. Choi, and H. C. Syn. 1995. Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am. J. Obstet. Gynecol. 172: 960-970.
33. Edwards, A. D., S. S. Diebold, E. M. Slack, H. Tomizawa, H. Hemmi, T. Kaisho, S. Akira, and C. Reis e Sousa. 2003. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur. J. Immunol. 33: 827-833. (Pubitemid 36546669)
34. Dasari, P., I. C. Nicholson, G. Hodge, G. W. Dandie, and H. Zola. 2005. Expression of toll-like receptors on B lymphocytes. Cell. Immunol. 236: 140-145. (Pubitemid 41771098)
35. O'Mahony, D. S., U. Pham, R. Iyer, T. R. Hawn, and W. C. Liles. 2008. Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages. Int. J. Med. Sci. 5: 1-8.
36. Hornung, V., S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdörfer, T. Giese, S. Endres, and G. Hartmann. 2002. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168: 4531-4537. (Pubitemid 34441357)
37. Jarrossay, D., G. Napolitani, M. Colonna, F. Sallusto, and A. Lanzavecchia. 2001. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31: 3388-3393. (Pubitemid 33100532)
38. Kadowaki, N., S. Ho, S. Antonenko, R. W. Malefyt, R. A. Kastelein, F. Bazan, and Y. J. Liu. 2001. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194: 863-869. (Pubitemid 32983021)
39. Zarember, K. A., and P. J. Godowski. 2002. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168: 554-561. (Pubitemid 34049553)
40. Illanes, S., M. Parra, R. Serra, K. Pino, H. Figueroa-Diesel, C. Romero, J. A. Arraztoa, L. Michea, and P. W. Soothill. 2009. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop pre-eclampsia and intrauterine growth restriction. Prenat. Diagn. 29: 1118-1122.
41. Swinkels, D. W., J. B. de Kok, J. C. Hendriks, E. Wiegerinck, P. L. Zusterzeel, and E. A. Steegers. 2002. Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin. Chem. 48: 650-653. (Pubitemid 34261231)
42. Murakami, K., K. Shimada, E. Maeda, T. Segawa, M. Shozu, and M. Inoue. 2003. Fetal DNA levels in maternal blood correlated with fetal prognosis in a case of intervillous hematoma. Am. J. Perinatol. 20: 361-366. (Pubitemid 37484655)